Literature DB >> 30093951

Emerging role of C5a/C5aR IL-17A axis in cGVHD.

Xiaomei Chen1,2, Peilong Lai2, Yulian Wang2, Chang He3, Suijing Wu2, Xin Huang2, Suxia Geng2, Chengwei Luo2, Wei Ling2, Lingji Zeng2, Peng Li4, Zhiwu Jiang4, Jianyu Weng2, Xin Du1,2.   

Abstract

Chronic graft-versus-host disease (cGVHD) manifests with features characteristic of autoimmune disease with organs attacked by pathogenic Th17 cells. However, the mechanism of Th17 cells generation in the setting of cGVHD is still unclear. Here we defined C5a/C5aR-IL-17Aaxis as a novel signaling that required in the pathologies of cGVHD. We firstly found a positive link between complement activation and the Th17 cells in patients with cGVHD. C5a, a critical component of complements, promoted the generation of Th17 cells in vitro and inhibition of the receptor for C5a (C5aR) reduced the Th17-bias response. Of note, C5aR blockade by PMX53 could suppress the generation of IL-17A-expressing Th17 cells and retard the onset and progression of cGVHD in vivo. Overall, our results provide new mechanistic insights that activation of C5a-C5aR signaling was required for IL-17A-induced immune responses in cGVHD and define novel molecular targets for developing effective therapeutics for cGVHD.

Entities:  

Keywords:  Chronic graft-versus-host disease (cGVHD); Complement C5a; Interleukin-17A (IL-17A); Th17 cells

Year:  2018        PMID: 30093951      PMCID: PMC6079133     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  31 in total

1.  Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17.

Authors:  Hisakazu Nishimori; Yoshinobu Maeda; Takanori Teshima; Haruko Sugiyama; Koichiro Kobayashi; Yoshiko Yamasuji; Sachiyo Kadohisa; Hidetaka Uryu; Kengo Takeuchi; Takehiro Tanaka; Tadashi Yoshino; Yoichiro Iwakura; Mitsune Tanimoto
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  Complement plays a central role in Candida albicans-induced cytokine production by human PBMCs.

Authors:  Shih-Chin Cheng; Tom Sprong; Leo A B Joosten; Jos W M van der Meer; Bart-Jan Kullberg; Bernhard Hube; Lone Schejbel; Peter Garred; Marcel van Deuren; Mihai G Netea
Journal:  Eur J Immunol       Date:  2012-04       Impact factor: 5.532

4.  Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus.

Authors:  Sudesh Pawaria; Kritika Ramani; Kelly Maers; Youhua Liu; Lawrence P Kane; Marc C Levesque; Partha S Biswas
Journal:  J Immunol       Date:  2014-08-22       Impact factor: 5.422

5.  Crosstalk between Toll like receptors and C5a receptor in human monocyte derived DCs suppress inflammatory cytokine production.

Authors:  Anouk Zaal; Suzanne N Lissenberg-Thunnissen; Gijs van Schijndel; Diana Wouters; S Marieke van Ham; Anja ten Brinke
Journal:  Immunobiology       Date:  2012-03-03       Impact factor: 3.144

6.  Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.

Authors:  Chunyan Zhang; Ivan Todorov; Zhifang Zhang; Yinping Liu; Fouad Kandeel; Stephen Forman; Samuel Strober; Defu Zeng
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

7.  C5a receptor signalling in dendritic cells controls the development of maladaptive Th2 and Th17 immunity in experimental allergic asthma.

Authors:  I Schmudde; H A Ströver; T Vollbrandt; P König; C M Karsten; Y Laumonnier; J Köhl
Journal:  Mucosal Immunol       Date:  2012-12-05       Impact factor: 7.313

8.  Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.

Authors:  Ryan Flynn; Jing Du; Rachelle G Veenstra; Dawn K Reichenbach; Angela Panoskaltsis-Mortari; Patricia A Taylor; Gordon J Freeman; Jonathan S Serody; William J Murphy; David H Munn; Stefanie Sarantopoulos; Leo Luznik; Ivan Maillard; John Koreth; Corey Cutler; Robert J Soiffer; Joseph H Antin; Jerome Ritz; Jason A Dubovsky; John C Byrd; Kelli P MacDonald; Geoff R Hill; Bruce R Blazar
Journal:  Blood       Date:  2014-05-12       Impact factor: 22.113

Review 9.  Mechanisms of rejection: role of complement.

Authors:  Conrad A Farrar; Steven H Sacks
Journal:  Curr Opin Organ Transplant       Date:  2014-02       Impact factor: 2.640

Review 10.  The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation.

Authors:  Ke Zhao; Qifa Liu
Journal:  J Hematol Oncol       Date:  2016-05-18       Impact factor: 17.388

View more
  3 in total

Review 1.  Interleukin-17 pathways in systemic sclerosis-associated fibrosis.

Authors:  Sakir Ahmed; Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2019-05-09       Impact factor: 2.631

Review 2.  Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics.

Authors:  Eleni Gavriilaki; Achilles Anagnostopoulos; Dimitrios C Mastellos
Journal:  Front Immunol       Date:  2019-02-27       Impact factor: 7.561

3.  The Gut Bacteria Dysbiosis Contributes to Chronic Graft-Versus-Host Disease Associated With a Treg/Th1 Ratio Imbalance.

Authors:  Yulian Wang; Lisi Huang; Tian Huang; Suxia Geng; Xiaomei Chen; Xin Huang; Peilong Lai; Xin Du; Jianyu Weng
Journal:  Front Microbiol       Date:  2022-09-08       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.